金城医药：关于子公司收到药品注册证书的公告

Group 1 - The core announcement is that Jincheng Pharmaceutical has received drug registration certificates for two products from the National Medical Products Administration [2] - The products include Bisoprolol Amlodipine Tablets and Cefdinir Dry Suspension, which are now officially registered for sale [2] - The registration is a significant step for the company's subsidiaries, Beijing Jincheng Tail Pharmaceutical Co., Ltd. and Shanghai Jincheng Suzhizhi Pharmaceutical Co., Ltd. [2]